We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay

News   Sep 13, 2017

 
Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay
 
 
Advertisement
 

RELATED ARTICLES

Algorithm Could Predict Risk of Heart Attack in Young People

News

Researchers have tested an algorithm on 700,000 patient records in east London, to find out if the data routinely collected by GPs can reveal cases of Familial Hypercholesterolemia - a leading cause of heart attack in young people. The study was published in the journal Heart.

READ MORE

Possible Link Between Prostate Cancer and Schizophrenia

News

Researchers have studied the polymorphisms of neurotransmitter metabolism genes in patients with prostate cancer.

READ MORE

SARS-CoV-2 Protease Cuts Human Proteins

News

Researchers have found targets of papain-like protease in the human proteome, including proteins involved in cardiovascular function, blood clotting and inflammation.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE